C2N Diagnostics Releases the PrecivityAD2™ Blood Test for Clinical Care, a Robust Assay with High Concordance to Amyloid PET and CSF streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PrecivityAD2 Aims to Set a New Performance Standard for Blood Biomarkers in Alzheimer’s Disease Diagnosis With Combined Measures of Amyloid Beta (Aβ42/40) and Tau Protein (p-tau217/np-tau217) RatiosPrecivity AD2 is Expected to Serve Major Unmet Need for an Accurate and Accessible Test Given the Availability of New D.